NCT07807384

Efficacy and Safety of an LVEF-Guided Mavacamten Dose Up-Titration Strategy in Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2026-09Est. Completion: 2026-09

Enrollment target: 115 participants

Contact

Cardiomyopathy, Hypertrophic Obstructive

The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of o…

Multiple LocationsEst. completion Oct 2028

Obstructive Hypertrophic Cardiomyopathy

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a p…

Anchorage, United StatesEst. completion Aug 17, 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.